JP2014510699A5 - - Google Patents

Download PDF

Info

Publication number
JP2014510699A5
JP2014510699A5 JP2013543901A JP2013543901A JP2014510699A5 JP 2014510699 A5 JP2014510699 A5 JP 2014510699A5 JP 2013543901 A JP2013543901 A JP 2013543901A JP 2013543901 A JP2013543901 A JP 2013543901A JP 2014510699 A5 JP2014510699 A5 JP 2014510699A5
Authority
JP
Japan
Prior art keywords
cancer
pharmaceutical composition
peptide
tumor
peptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013543901A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014510699A (ja
JP6087289B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/003053 external-priority patent/WO2012080822A2/en
Publication of JP2014510699A publication Critical patent/JP2014510699A/ja
Publication of JP2014510699A5 publication Critical patent/JP2014510699A5/ja
Application granted granted Critical
Publication of JP6087289B2 publication Critical patent/JP6087289B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013543901A 2010-12-14 2011-12-14 Napi2b輸送体に対するヒト化モノクローナル抗体の相補性決定領域に由来する抗腫瘍ペプチド Active JP6087289B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42285610P 2010-12-14 2010-12-14
US61/422,856 2010-12-14
PCT/IB2011/003053 WO2012080822A2 (en) 2010-12-14 2011-12-14 Antitumor peptide derived from a complementarity determining region of a humanized monoclonal antibody to napi2b transporter

Publications (3)

Publication Number Publication Date
JP2014510699A JP2014510699A (ja) 2014-05-01
JP2014510699A5 true JP2014510699A5 (cg-RX-API-DMAC7.html) 2015-02-05
JP6087289B2 JP6087289B2 (ja) 2017-03-01

Family

ID=46245158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013543901A Active JP6087289B2 (ja) 2010-12-14 2011-12-14 Napi2b輸送体に対するヒト化モノクローナル抗体の相補性決定領域に由来する抗腫瘍ペプチド

Country Status (8)

Country Link
US (2) US9193797B2 (cg-RX-API-DMAC7.html)
EP (1) EP2654769B1 (cg-RX-API-DMAC7.html)
JP (1) JP6087289B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013015001B1 (cg-RX-API-DMAC7.html)
CO (1) CO6721014A2 (cg-RX-API-DMAC7.html)
ES (1) ES2804476T3 (cg-RX-API-DMAC7.html)
PT (1) PT2654769T (cg-RX-API-DMAC7.html)
WO (1) WO2012080822A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105828840B (zh) * 2013-12-16 2020-08-04 基因泰克公司 1-(氯甲基)-2,3-二氢-1H-苯并[e]吲哚二聚体抗体-药物缀合物化合物及使用和治疗方法
CN105491524B (zh) * 2015-12-11 2019-04-26 小米科技有限责任公司 一种确定目标便携设备位置的方法和装置
EP3648792A4 (en) * 2017-07-01 2021-07-21 Recepta Biopharma S.A. IMMUNOMODULATOR PEPTIDES AND METHODS FOR MODULATING THE IMMUNE SYSTEM IN A SUBJECT
JP7279026B2 (ja) * 2017-09-20 2023-05-22 メルサナ セラピューティクス インコーポレイテッド Napi2b標的化療法に対する応答を予測するための組成物および方法
CN116194138A (zh) 2020-08-07 2023-05-30 博德研究所 治疗性靶向癌症中经由xpr1:kidins220蛋白质复合物的磷酸盐调节异常
KR102822203B1 (ko) 2020-12-29 2025-06-18 삼성전자주식회사 전력 공급 장치를 이용하여 오디오 출력 장치를 찾는 방법 및 그 전력 공급 장치
CN116514926B (zh) * 2023-06-25 2023-08-29 烟台药物研究所 一种抗肿瘤阳离子两亲肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108652D0 (en) * 1991-04-23 1991-06-12 Antisoma Ltd Immunoreactive compounds
AU684348B2 (en) * 1994-06-07 1997-12-11 Nihon Medi-Physics Co., Ltd. Tumor affinity peptide, and radioactive diagnostic agent and adioactive therapeutic agent containing the peptide
US6689753B1 (en) 1999-11-05 2004-02-10 Axonyx, Inc. β sheet breaker peptide analogs that inhibit β pleated sheet formation in amyloid β-peptide
WO2005040219A1 (en) * 2003-10-28 2005-05-06 Novo Nordisk A/S Laminin-5 gamma2-binding peptides, related compositions, and use thereof
WO2009097128A1 (en) * 2008-01-29 2009-08-06 Ludwig Institute For Cancer Research Ltd. Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy

Similar Documents

Publication Publication Date Title
JP2014510699A5 (cg-RX-API-DMAC7.html)
JP2012521768A5 (cg-RX-API-DMAC7.html)
JP2014506913A5 (cg-RX-API-DMAC7.html)
JP2016538344A5 (cg-RX-API-DMAC7.html)
JP2009505676A5 (cg-RX-API-DMAC7.html)
JP2020525429A5 (cg-RX-API-DMAC7.html)
TWI853790B (zh) 細胞穿透肽序列
JP2017536344A5 (cg-RX-API-DMAC7.html)
JP2015519891A5 (cg-RX-API-DMAC7.html)
IL257219A (en) Prodrugs of glutamine analogs
JP2016528162A5 (cg-RX-API-DMAC7.html)
JP2016519062A5 (cg-RX-API-DMAC7.html)
TWI609687B (zh) 平滑肌肉瘤之標靶性治療
TW202100183A (zh) 雙配體藥物複合體及其用途
JP2012502938A5 (cg-RX-API-DMAC7.html)
TR201906470T4 (tr) İmmünomodülatörler.
RU2013104830A (ru) Лечение рака при помощи направленных на мишень антител in vivo
JP2019513734A5 (cg-RX-API-DMAC7.html)
JP2019512478A5 (cg-RX-API-DMAC7.html)
JP2013172743A5 (cg-RX-API-DMAC7.html)
JP2014500870A5 (cg-RX-API-DMAC7.html)
JP2010001302A5 (cg-RX-API-DMAC7.html)
JP2016527273A5 (cg-RX-API-DMAC7.html)
JP2014533247A5 (cg-RX-API-DMAC7.html)
JP2015512398A5 (cg-RX-API-DMAC7.html)